Last reviewed · How we verify
Seasonal Influenza DNA vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Seasonal Influenza DNA vaccine (Seasonal Influenza DNA vaccine) — National Institute of Allergy and Infectious Diseases (NIAID).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Seasonal Influenza DNA vaccine TARGET | Seasonal Influenza DNA vaccine | National Institute of Allergy and Infectious Diseases (NIAID) | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Seasonal Influenza DNA vaccine CI watch — RSS
- Seasonal Influenza DNA vaccine CI watch — Atom
- Seasonal Influenza DNA vaccine CI watch — JSON
- Seasonal Influenza DNA vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Seasonal Influenza DNA vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/seasonal-influenza-dna-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab